Home HDT Bio and UTMB Awarded MCDC Innovation Prototype Grant to Advance CCHF Vaccine HDT-321 into Phase 1 Clinical Trial

HDT Bio and UTMB Awarded MCDC Innovation Prototype Grant to Advance CCHF Vaccine HDT-321 into Phase 1 Clinical Trial

May 22, 2026 00:00 CST Updated 00:17